_HOME | _RSS
View Article
KRAS Mutations Predictive But Not Prognostic in Colorectal Cancer
Wednesday, July 02, 2008 - 05:27 AM - 5 months ago - Presse spécialisée - Medscape hematology oncology
Another study has confirmed that KRAS mutations predict response to cetuximab in colorectal cancer, but shows that they are not prognostic. Medscape Medical News






